279 results match your criteria: "Saint Andre Hospital[Affiliation]"

Introduction: Generalized pustular psoriasis (GPP) is a rare, potentially life-threatening, neutrophilic, autoinflammatory skin disease characterised by recurrent flares of generalised sterile pustules and associated systemic features. Inconsistent diagnostic criteria and a lack of approved therapies pose serious challenges to GPP management. Our objectives were to discuss the challenges encountered in the care of patients with GPP and identify healthcare provider (HCP) educational needs and clinical practice gaps in GPP management.

View Article and Find Full Text PDF
Article Synopsis
  • The introduction of antiangiogenic treatments and immune checkpoint inhibitors has transformed how metastatic clear cell renal cell cancer is treated, particularly through combination therapies that outperform sunitinib alone.
  • Phase III trials favor combinations like pembrolizumab + axitinib, cabozantinib + nivolumab, and lenvatinib + pembrolizumab as first-line treatments, along with nivolumab + ipilimumab for higher-risk patients.
  • Ongoing challenges include determining the optimal combination for individual patients, assessing PD-L1 status, and addressing strategies for second-line therapies.
View Article and Find Full Text PDF

Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.

Br J Dermatol

March 2022

Sorbonne Université, AP-HP, Hôpital Saint Antoine, Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), Paris, France.

Background: A new autoinflammatory syndrome related to somatic mutations of UBA1 was recently described and called VEXAS syndrome ('Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome').

Objectives: To describe clinical characteristics, laboratory findings and outcomes of VEXAS syndrome.

Methods: One hundred and sixteen patients with VEXAS syndrome were referred to a French multicentre registry between November 2020 and May 2021.

View Article and Find Full Text PDF
Article Synopsis
  • Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious drug reactions that can lead to high mortality rates, and there’s no agreed-upon treatment plan across Europe.
  • * A retrospective study involving 212 adults aimed to identify treatment methods, risk factors, and outcomes for patients with SJS/TEN in 13 centers from 2015 to 2019, revealing that most patients had identified culprit drugs, primarily antibiotics and anticonvulsants.
  • * The findings showed that 63.7% of patients experienced severe complications, with a 20.8% mortality rate within 6 weeks, and significant body surface area detachment was linked to more severe outcomes.
View Article and Find Full Text PDF

Objectives: Within the context of the wide use of fluoroquinolones (FQs) and the emergence of multidrug-resistant bacteria, French recommendations concerning the appropriate use of systemic FQs in adults were published in 2015. This study assessed the impact of antibiotic stewardship intervention on the use of FQs over a 5-year period.

Methods: Five annual audits were performed to evaluate FQ prescriptions.

View Article and Find Full Text PDF

French recommendations for the management of systemic sclerosis.

Orphanet J Rare Dis

July 2021

Service de Médecine Interne, Centre de Référence Maladies Autoimmunes Systémiques Rares D'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), APHP-CUP, Hôpital Cochin, Université de Paris, 75014, Paris, France.

Systemic sclerosis (SSc) is a generalized disease of the connective tissue, arterioles, and microvessels, characterized by the appearance of fibrosis and vascular obliteration. There are two main phenotypical forms of SSc: a diffuse cutaneous form that extends towards the proximal region of the limbs and/or torso, and a limited cutaneous form where the cutaneous sclerosis only affects the extremities of the limbs (without passing beyond the elbows and knees). There also exists in less than 10% of cases forms that never involve the skin.

View Article and Find Full Text PDF

Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis.

Autoimmun Rev

October 2021

UMR CNRS5164, ImmunoconcEpT, Bordeaux University, Bordeaux, France; Internal Medicine Department, Haut-Lévêque Hospital, Bordeaux, France; ACRONIM University Hospital Federation, Bordeaux, France.

Objective: To study whether adding repeated 125 mg methyl-prednisolone pulses (MP) to Eurolupus fortnightly intravenous cyclophosphamide (CYC) improves remission of lupus nephritis (LN) compared with recommended schedules.

Methods: Observational comparative study of patients with biopsy-confirmed class III, IV or V LN: 30 in the mycophenolate (MMF) group, 25 in the CYC group and 38 in the CYC-MP group. The main efficacy outcome was complete response at 12 months.

View Article and Find Full Text PDF

The present paper provides an update of previous recommendations on Home Blood Pressure Monitoring from the European Society of Hypertension (ESH) Working Group on Blood Pressure Monitoring and Cardiovascular Variability sequentially published in years 2000, 2008 and 2010. This update has taken into account new evidence in this field, including a recent statement by the American Heart association, as well as technological developments, which have occurred over the past 20 years. The present document has been developed by the same ESH Working Group with inputs from an international team of experts, and has been endorsed by the ESH.

View Article and Find Full Text PDF

Objectives: Sustained virological response (SVR) decreases the risk of hepatitis C virus (HCV)-related events. Nevertheless, a substantial risk of events persists. We estimated incidences and identified factors associated with severe clinical events after SVR following treatment with a direct-acting antiviral (DAA) in HIV/HCV-coinfected patients.

View Article and Find Full Text PDF

Background: Trichoblastoma (TB) is an uncommon benign follicular tumour for which clinical data is limited since most reports originate from pathology studies.

Objective: To describe the clinical aspects of TB.

Methods: This is an ancillary study of a prospective multicentre cohort of 2710 clinically suspected basal cell carcinoma (BCC), including 935 nodular BCCs.

View Article and Find Full Text PDF

To describe real-world pembrolizumab administration and outcomes for advanced melanoma in France. Using the MelBase longitudinal database, this multicenter historical-prospective study examined treatment and outcomes of patients with nonuveal, unresectable stage III/IV melanoma initiating pembrolizumab from April 2016 to September 2017, with follow-up to September 2019. Kaplan-Meier time-to-event analyses were conducted.

View Article and Find Full Text PDF

Locoregional Treatments for Digital Ulcers in Systemic Sclerosis: A Systematic Review.

Acta Derm Venereol

June 2021

Department of Dermatology and Paediatric Dermatology, National Reference Center for Rare Skin Diseases, Saint-André Hospital, FR-33000 Bordeaux, France.

The management of digital ulcers in systemic sclerosis is difficult. While the 2017 European League Against Rheumatism (EULAR) guidelines clearly defined the use of systemic therapies for digital ulcers, little is known about the efficacy of locoregional treatments. The aim of this review is to systematically assess the spectrum of published locoregional therapies for digital ulcers.

View Article and Find Full Text PDF

Background: Working in the ICU during the first COVID-19 wave was associated with high levels of mental health disorders.

Research Question: What are the mental health symptoms in health care providers (HCPs) facing the second wave?

Study Design And Methods: A cross-sectional study (October 30-December 1, 2020) was conducted in 16 ICUs during the second wave in France. HCPs completed the Hospital Anxiety and Depression Scale, the Impact of Event Scale-Revised (for post-traumatic stress disorder), and the Maslach Burnout Inventory.

View Article and Find Full Text PDF

Clinical and laboratory predictors of COVID-19 severity are now well described and combined to propose mortality or severity scores. However, they all necessitate saturable equipment such as scanners, or procedures difficult to implement such as blood gas measures. To provide an easy and fast COVID-19 severity risk score upon hospital admission, and keeping in mind the above limits, we sought for a scoring system needing limited invasive data such as a simple blood test and co-morbidity assessment by anamnesis.

View Article and Find Full Text PDF

This study aims to assess the efficacy and safety of convalescent plasma therapy (CPT) in COVID-19 critically ill patients with protracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNAemia. A retrospective cohort study was conducted in intensive care unit (ICU). All patients with severe COVID-19 pneumonia for whom RNAemia remained positive more than 14 days after onset of the infection were included and given CPT.

View Article and Find Full Text PDF
Article Synopsis
  • GCA (Giant Cell Arteritis) is a type of vasculitis where the triggers are unknown, and the study aims to explore the effects of JAK2p.V617F-mutated myeloproliferative neoplasms (MPNs) on GCA patients while also screening for clonal hematopoiesis (CH) in those without MPNs.
  • In a retrospective study, 21 GCA patients with MPNs were compared to 42 GCA patients without MPNs, revealing that those with MPNs had fewer cephalic symptoms and higher platelet counts, while their overall survival was significantly shorter.
  • The study detected CH mutations in 33% of GCA patients
View Article and Find Full Text PDF

Background: Most cases of Stevens-Johnson syndrome and toxic epidermal necrolysis are drug-induced. A small subset of cases remain with unknown aetiology (idiopathic epidermal necrolysis [IEN]).

Objective: We sought to better describe adult IEN and understand the aetiology.

View Article and Find Full Text PDF

[The CD40-CD40L axis: Current and future implications in clinical immunology].

Rev Med Interne

October 2021

Department of Internal Medicine and Clinical Immunology, University Hospital Centre of Bordeaux, Saint-André Hospital, 33000 Bordeaux, France; CNRS UMR 5164, Immuno ConcEpT, Bordeaux University, 33076 Bordeaux, France.

The CD40-CD40 ligand (CD40L) pathway is a backbone of communication between cells of the immune system. It makes it possible to generate a proinflammatory signal and thus participates in the pathogenesis of dysimmune diseases, transplant rejection and atherosclerosis. Because of this therapeutic target of choice, several generations of anti-CD40L monoclonal antibodies have emerged since the 1990s.

View Article and Find Full Text PDF

Background: IDH-mutant anaplastic astrocytomas (AAs) are chemosensitive tumors for which the best choice of adjuvant chemotherapy between procarbazine, lomustine, and vincristine (PCV) or temozolomide (TMZ) after radiotherapy (RT) remains unclear.

Methods: In a large cohort of patients with histologically proven 2016 World Health Organization classification AA with IDH1/2 mutations included in the French national POLA cohort (n = 355), the primary objective was to compare progression-free survival (PFS) between the two treatment regimens (n = 311). Secondary endpoints were overall survival (OS), progression type, pseudoprogression rate, and toxicity.

View Article and Find Full Text PDF

Primary lymphedema is a rare chronic pathology associated with constitutional abnormalities of the lymphatic system. The objective of this French National Diagnosis and Care Protocol (Protocole National de Diagnostic et de Soins; PNDS), based on a critical literature review and multidisciplinary expert consensus, is to provide health professionals with an explanation of the optimal management and care of patients with primary lymphedema. This PNDS, written by consultants at the French National Referral Center for Primary Lymphedema, was published in 2019 ( https://has-sante.

View Article and Find Full Text PDF

Several international guidelines concerning lower extremity arterial disease (LEAD) have been published recently, in particular, by the American Heart Association the European Society of Cardiology/European Society for Vascular Surgery, the European Society for Vascular Medicine and the Society for Vascular Surgery. These guidelines differ in some respects and certain issues are not addressed. The objective of this consensus driven by the French Societies of vascular Medicine and surgery was to analyze the disparities between the different guidelines, as well as certain issues not covered, and develop proposals with regard to these points.

View Article and Find Full Text PDF